PLAU and psoriasis: Analyses of human psoriatic skin and studies in genetically engineered mouse models revealed that FAM3C/ILEI contributes to psoriasis by controlling keratinocyte hyperproliferation, differentiation, and neutrophil recruitment and identifies uPA, a regulator of ILEI secretion, as a druggable target.